Interleukin 6 Plays a Role in the Migration of Magnetically Levitated Mesenchymal Stem Cells Spheroids

Mesenchymal stem cells (MSCs) reside quiescently within a specialised ‘niche’ environment in the bone marrow. However, following appropriate signalling cues, MSCs mobilise and migrate out from the niche, typically toward either sites of injury (a regenerative response) or toward primary tumours (an intrinsic homing response, which promotes MSCs as cellular vectors for therapeutic delivery). To date, very little is known about MSC mobilisation. By adopting a 3D MSC niche model, whereby MSC spheroids are cultured within a type I collagen gel, recent studies have highlighted interleukin-6 (IL-6) as a key cytokine involved in MSC migration. Herein, the ability of IL-6 to induce MSC migration was further investigated, and the key matrix metalloproteinases used to effect cell mobilisation were identified. Briefly, the impact of IL-6 on the MSC migration in a two-dimensional model systems was characterised—both visually using an Ibidi chemotaxis plate array (assessing for directional migration) and then via a standard 2D monolayer experiment, where cultured cells were challenged with IL-6 and extracted media tested using an Abcam Human MMP membrane antibody array. The 2D assay displayed a strong migratory response toward IL-6 and analysis of the membrane arrays data showed significant increases of several key MMPs. Both data sets indicated that IL-6 is important in MSC mobilisation and migration. We also investigated the impact of IL-6 induction on MSCs in 3D spheroid culture, serving as a simplistic model of the bone marrow niche, characterised by fluorescently tagged magnetic nanoparticles and identical membrane antibody arrays. An increase in MMP levels secreted by cells treated with 1 ng/mL IL-6 versus control conditions was noted in addition to migration of cells away from the central spheroid mass.

[1]  J. Mesirov,et al.  Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. , 2008, Cancer research.

[2]  T. Georg,et al.  Quantitative analysis of proinflammatory cytokines (IL-1β, IL-6, TNF-α) in human skin wounds , 2000 .

[3]  K. Brew,et al.  Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.

[4]  D. Banerjee,et al.  Differential Gene Expression Associated with Migration of Mesenchymal Stem Cells to Conditioned Medium from Tumor Cells or Bone Marrow Cells , 2007, Stem cells.

[5]  S. Bruder,et al.  Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. , 2001, Trends in molecular medicine.

[6]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.

[7]  P. Orcel,et al.  Bone loss: Factors that regulate osteoclast differentiation - an update , 2000, Arthritis Research & Therapy.

[8]  L. Kanz,et al.  Novel Markers for the Prospective Isolation of Human MSC , 2007, Annals of the New York Academy of Sciences.

[9]  A. Mantovani,et al.  The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. , 1991, Journal of immunology.

[10]  P. Mattila,et al.  Filopodia: molecular architecture and cellular functions , 2008, Nature Reviews Molecular Cell Biology.

[11]  V. Fowler,et al.  Osteoblasts express the inflammatory cytokine interleukin-6 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. , 2004, The American journal of pathology.

[12]  Ardeshir Ghavamzadeh,et al.  BMC Cell Biology BioMed Central Research article Aging of mesenchymal stem cell in vitro , 2005 .

[13]  H. Yagi,et al.  Mesenchymal Stem Cell Therapy: Immunomodulation and Homing Mechanisms , 2012 .

[14]  N. Nardi,et al.  In Search of the In Vivo Identity of Mesenchymal Stem Cells , 2008, Stem cells.

[15]  D. Banerjee,et al.  Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu. , 2010, Experimental cell research.

[16]  C. Overall,et al.  Identification, regulation and role of tissue inhibitor of metalloproteinases‐4 (TIMP‐4) in human platelets , 2002, British journal of pharmacology.

[17]  R. Tuan,et al.  Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy , 2004, Journal of cellular and molecular medicine.

[18]  Catherine C. Berry,et al.  Functionalisation of magnetic nanoparticles for applications in biomedicine : Biomedical applications of magnetic nanoparticles , 2003 .

[19]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[20]  S. Pastoreková,et al.  Preparation of poly-L-lysine functionalized magnetic nanoparticles and their influence on viability of cancer cells , 2017 .

[21]  C. Berry,et al.  Magnetically levitated mesenchymal stem cell spheroids cultured with a collagen gel maintain phenotype and quiescence , 2017, Journal of tissue engineering.

[22]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[23]  A. Hursthouse,et al.  A Quiescent, Regeneration-Responsive Tissue Engineered Mesenchymal Stem Cell Bone Marrow Niche Model via Magnetic Levitation. , 2016, ACS nano.

[24]  Yahan Fan,et al.  CXCL12/CXCR4 axis promotes mesenchymal stem cell mobilization to burn wounds and contributes to wound repair. , 2013, The Journal of surgical research.

[25]  Roopa R. Nadig Stem cell therapy – Hype or hope? A review , 2009, Journal of conservative dentistry : JCD.

[26]  Effects of matrix metalloproteinases on the fate of mesenchymal stem cells , 2016, Stem Cell Research & Therapy.

[27]  Liju Yang,et al.  Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. , 2014, Assay and drug development technologies.

[28]  K. Arihiro,et al.  Cytokines facilitate chemotactic motility of breast carcinoma cells , 2000, Breast cancer.

[29]  M. Alini,et al.  Concise Review: Bone Marrow‐Derived Mesenchymal Stem Cells Change Phenotype Following In Vitro Culture: Implications for Basic Research and the Clinic , 2014, Stem cells.

[30]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[31]  M. A. Leroux,et al.  Concise Review: Role of Mesenchymal Stem Cells in Wound Repair , 2012, Stem cells translational medicine.

[32]  K. Ishihara,et al.  Interleukin-6 Directly Inhibits Osteoclast Differentiation by Suppressing Receptor Activator of NF-κB Signaling Pathways* , 2008, Journal of Biological Chemistry.

[33]  A. Trumpp,et al.  The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in , 2011, The Journal of experimental medicine.

[34]  Georges Noel,et al.  Three-Dimensional Cell Culture: A Breakthrough in Vivo , 2015, International journal of molecular sciences.

[35]  C. Scheiermann,et al.  Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. , 2013, Annual review of immunology.

[36]  M. Chopp,et al.  MCP-1, MIP-1, IL-8 and Ischemic Cerebral Tissue Enhance Human Bone Marrow Stromal Cell Migration in Interface Culture , 2002, Hematology.

[37]  R. MacCallum,et al.  Stress-related modulation of matrix metalloproteinase expression , 2002, Journal of Neuroimmunology.

[38]  C. Verfaillie,et al.  Mesenchymal Stem Cells Migration Homing and Tracking , 2013, Stem cells international.

[39]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[40]  A. Hursthouse,et al.  The influence of particle size and static magnetic fields on the uptake of magnetic nanoparticles into three dimensional cell-seeded collagen gel cultures. , 2015, Journal of biomedical materials research. Part B, Applied biomaterials.

[41]  Andrew J. Ewald,et al.  Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.

[42]  Christopher S. Chen,et al.  Engineering cellular microenvironments to improve cell-based drug testing. , 2002, Drug discovery today.

[43]  D. Livingston,et al.  Impact of enhanced mobilization of bone marrow derived cells to site of injury. , 2011, The Journal of trauma.